SCHEMBL6707723

SCHEMBL6707723

N#Cc1ccc(NC(=O)c2noc3ccc(Br)cc23)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.39
GPR35 Q9HC97 1/20 0.36
HIF1A Q16665 5/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ROCK1 Q13464 1/20 0.32
CXCR1 P25024 1/20 0.32
CXCR2 P25025 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709887 0.91 GRIK1 (0.43) GRIK1HIF1AMEN1KMT2AMAPT
SCHEMBL6711761 0.89 HIF1A (0.34) GRIK1HIF1AMAPTROCK1NOS3
SCHEMBL6714271 0.88 HIF1A (0.48) HIF1AROCK1
SCHEMBL6713809 0.87 HIF1A (0.43) HIF1AROCK1CXCR1CXCR2
SCHEMBL6710163 0.87 HIF1A (0.43) HIF1AMAPTTP53POLB
SCHEMBL6707777 0.87 HIF1A (0.38) HIF1AMAPTROCK1TP53POLB
SCHEMBL6707767 0.86 HIF1A (0.42) HIF1AMEN1KMT2AMAPTRAB9A
SCHEMBL6708659 0.86 GRIK1 (0.51) GRIK1GPR35HIF1AMEN1KMT2A
SCHEMBL6709290 0.85 GPR35 (0.34) GPR35HIF1AMEN1KMT2AMAPT
SCHEMBL6710158 0.85 F2 (0.44) HIF1AMEN1KMT2ARAB9AROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885GPR35 2928/4885HIF1A 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.